KRRO
Korro BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KRRO Profile
Korro Bio, Inc.
A company that develops therapeutics to treat patients suffering from sensorineural hearing loss
Biological Technology
11/13/2014
10/03/2019
NASDAQ Stock Exchange
104
12-31
Common stock
60 First Street, 2nd Floor, Suite 250, Cambridge, MA 02141
--
Korro Bio, Inc., a Delaware corporation, was incorporated on November 13, 2014. The company is a biopharmaceutical company whose mission is to discover, develop and commercialize a new class of genetic medicines based on editing RNA that can treat rare and highly prevalent diseases. The company is generating a portfolio of differentiated programs designed to leverage the body's natural RNA editing process for precise but short-lived single-base editing.
